291MO - Coping strategies and performance status among patients with advanced cancer in Indonesia

Background

Performance status among patients with advanced cancer may impact significantly on their prognosis, quality of life, and survival. Proper coping strategies may optimalize performance status among patients with advanced cancer. The purposes of this study were to explore the coping strategies used by patients with advanced cancer in Indonesia. In addition, the determinants of performance status, including sociodemoghraphic and clinical characteristics, as well as coping strategies, were also examined.

Methods

This cross-sectional study collected demographic data, clinical characteristic and coping measurements from 440 patients with advanced cancer in Indonesia. The Brief Cope Inventory was used to assess coping strategies which can be classified into Problem Focused Coping (PFC) and Emotional Focused Coping (EFC). The Karnofsky Performance Scale was used to assess the Performance status. Descriptive analysis, Mann-Whitney U test, Kruskal-Wallis test, and multiple linear regression with stepwise method were used to analyze the data.

Results

The 3 most often used coping strategies were religion followed by emotional support and acceptance. PFC was asscociated with stage of diseases and time of diagnosis. EFC did not related to any demoghraphic variable and clinical characteristic. The determinants of functional status were higher education and PFC. Subjects who reported a higher education and higher EFC score were associated with better performance status. however, higher PFC score was found to be negatively related to performance status.

Conclusions

Patients with advanced cancer in Indonesia predominantly used PFC particularly religion coping strategy. Proper interventions to optimize performance status for patients with advanced cancer should be incorprating appropriate type of coping strategies and identifying related factors in Indonesia taking into account possible culture characteristics such as religion.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.